DNA Print Genomics Net Income

The latest net income for DNAG is $-4.6M as of September 2007. That compares with $-13M in the prior-year period — up 66.1% year over year. That is below the Healthcare sector average of $16B. Investors often review this figure alongside DNA Print Genomics's historical trend and sector peers before judging valuation or financial health.

Over the past year, DNAG's net income moved from $-13M to $-4.6M — a 66.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in DNA Print Genomics's operating scale or balance-sheet position.

Against Healthcare companies, DNAG currently prints $-4.6M for net income, while the sector average sits near $16B. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at DNA Print Genomics's growth, margins, and balance sheet.

A net income figure of $-4.6M for DNAG is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $16B. Explore the charts below for those layers of context.

After noting DNAG's net income ($-4.6M), review year-over-year change from $-13M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.